2022 American Transplant Congress
The Impact of Donor Nephrectomy on the Living Donors Aged 75 Years and Older
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
*Purpose: Due to the profound organ shortage, number of living donor kidney transplantation (LDKT) from elder living donor (LD) is increasing. However, there has been…2022 American Transplant Congress
A Pilot Study Using Registry-Based External Controls for the Cyclosporine Arm of the BENEFIT Study
1Transplant Therapeutics Consortium, Critical Path Institute, Tucson, AZ, 2UNOS, Richmond, VA
*Purpose: The Transplant Therapeutics Consortium established a real-world evidence workgroup evaluating the potential of supplementing internal control arms with external controls to understand the impact…2022 American Transplant Congress
Modification of Gut Microbiota Accelerates Kidney Repair After Experimental Ischemia Reperfusion Injury
Johns Hopkins Medicine, Baltimore, MD
*Purpose: Kidney ischemia reperfusion injury (IRI) leads to changes in gut microbiome, and pre-IR microbiome changes can modify course of experimental tissue injury. There is…2022 American Transplant Congress
Cortex Recipient Weight Ratio is a Predictor for Short-Term Renal Function After Living Donor Kidney Transplant
*Purpose: Renal function early after living donor kidney transplant (LDKT) depends on “nephron mass” in the renal graft, and “nephron mass” can be quantified as…2022 American Transplant Congress
Expanded Criteria Donor with Severe Acute Kidney Injury: Worth to Use?
*Purpose: Because of organ shortage, the world facing problem, expanded criteria donor (ECD) was utilized to increase donor pool. Although long term allograft survival from…2022 American Transplant Congress
Donor-Derived Cell-Free DNA (dd-cfDNA) for Assessment of Response After Treatment of Allograft Rejection
*Purpose: Surveillance of dd-cfDNA after therapy for rejection represents a promising strategy for monitoring post-treatment response. We assessed post-rejection kinetics of dd-cfDNA among kidney transplant…2022 American Transplant Congress
Patient-Reported Barriers to Living Kidney Donor Follow-Up
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Despite regulations mandating follow-up laboratory testing for living kidney donors, less than half of transplant centers are in compliance. We sought to understand barriers…2022 American Transplant Congress
Glomerular Filtration Rates (GFR) Reference Values for Living Kidney Donors Using the 2021 CKD-EPI Equation without the Race Factor
Cleveland Clinic, Cleveland, OH
*Purpose: Kidney function is central to donor evaluation and KDIGO guidelines recommend using estimated GFR (eGFR) for initial screening. A new creatinine-based CKD-EPI equation ('21…2022 American Transplant Congress
Impact of Belatacept Conversion on Renal Function and Donor Specific Antibodies in Renal Transplant Recipients
Northwestern Memorial Hospital, Chicago, IL
*Purpose: Although associated with nephrotoxicity, calcineurin inhibitors (CNI) have historically been the cornerstone of immunosuppression. Belatacept, a co-stimulation blocker, is FDA-approved for de novo use…2022 American Transplant Congress
Kidney Transplant Recipients Not Reaching the Expected Post-Transplant Creatinine Range Most Likely Show Calcineurin-Inhibitor Nephrotoxicity Upon Histology
1University Hospital Zürich, Zürich, Switzerland, 2University Hospital Zurich, Zürich, Switzerland
*Purpose: Very recently, our own data suggested that approximately 25% of deceased-donor kidney transplant recipients (KTRs) and 10% of living-donor KTRs don’t reach the expected…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 19
- Next Page »